“…Routine contrast-enhanced, dynamic susceptibilityweighted MR imaging has already proven to be of clinical value, in order to distinguish between different tumor types of the human brain (Boxerman et al, 2006;Donahue et al, 2000;Hartmann et al, 2003;Law et al, 2006;Provenzale et al, 2002). The purpose of this study was to develop a setup for advanced tumor mapping using DSC-MRI, at a clinical MRI scanner with standard surface coils in a rat model.…”